@jakeskjult.bsky.social
The study strengthens the case for using non‑invasive MRI biomarkers to pick the right glioblastoma patients for targeted therapies. NWBO’s cell‑based DCVax‑L could ultimately benefit from similar precision‑medicine approaches (selecting patients who might gain most from a DC vaccine ± bevacizumab).
April 17, 2025 at 11:41 AM
The study strengthens the case for using non‑invasive MRI biomarkers to pick the right glioblastoma patients for targeted therapies. NWBO’s cell‑based DCVax‑L could ultimately benefit from similar precision‑medicine approaches (selecting patients who might gain most from a DC vaccine ± bevacizumab).
Hello Secretary Clinton! I voted for you !!
April 1, 2025 at 5:48 PM
Hello Secretary Clinton! I voted for you !!
and 5000 Bluesky followers ?!? :)
December 29, 2024 at 5:52 PM
and 5000 Bluesky followers ?!? :)